Advertisement

U.S. markets open in 4 hours 34 minutes

S&P Futures
4,350.75
+25.25(+0.58%)
Dow Futures
33,889.00
+164.00(+0.49%)
Nasdaq Futures
14,984.50
+118.00(+0.79%)
Russell 2000 Futures
1,809.00
+10.40(+0.58%)
Crude Oil
91.21
+0.42(+0.46%)
Gold
1,857.20
-8.90(-0.48%)

Advertisement

Athenex, Inc. (ATNXQ)

Other OTC - Other OTC Delayed Price. Currency in USD

0.0152

0.0000

(0.00%)

At close: 01:49PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	0.0152
Open	0.0152
Bid	N/A x N/A
Ask	N/A x N/A
Day's Range	0.0152 - 0.0152
52 Week Range	0.0010 - 6.0000
Volume	2,036
Avg. Volume	16,676

Market Cap	132,287
Beta (5Y Monthly)	0.79
PE Ratio (TTM)	N/A
EPS (TTM)	-14.9800
Earnings Date	Oct 02, 2023 - Oct 12, 2023
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	2.50

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ATNXQ

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Athenex, Inc.
CYTK: Rating increased to a HOLDCYTOKINETICS INC has an Investment Rating of HOLD; a target price of $24.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.
Rating
Fair Value
Economic Moat
5 days agoArgus Research